Abstract
Background and aim
Colorectal cancer is the third most common cancer and 3rd leading cause of cancer-related death in the USA. African Americans (AA) have inferior outcomes when matched for diagnosis stage and socioeconomic situation. Nutritional status, at diagnosis and its contribution to the observed cancer outcome disparity, between AA and non-Hispanic whites (nHw) has not been evaluated to date. The aim of the investigation was to determine if differences in nutritional surrogate markers, such as serum albumin and body mass index (BMI), exist at the time of colorectal cancer diagnosis between AA and nHw.
Methods
The University of Florida College of Medicine-Jacksonville endoscopy database was reviewed for all patients with a biopsied colorectal mass between January 2000 and December 2007. Patients were excluded if histology did not reveal colorectal adenocarcinoma or albumin/BMI was unavailable. Demographic data, tumor location, serum albumin within 60 days of diagnosis, presence of diabetes along with serum HbA1c were obtained.
Results
During the study period, 321 patients had colorectal masses discovered and 156 met entry criteria. There was no difference between ethnic groups regarding gender distribution, tumor location, diabetes presence, or BMI. Mean albumin was significantly less in AA compared to nHw (p < 0.01). This persisted after adjustment for gender, presence/absence of diabetes, and BMI.
Conclusions
Lower albumin levels in AA indicate poorer nutritional status at colorectal cancer diagnosis compared to nHw. This may contribute to the outcome disparities observed between AA and nHw. Aggressive nutritional interventions to reverse this disparity should be evaluated.
Similar content being viewed by others
References
American Cancer Society (2009) Cancer Facts and Figures 2009. American Cancer Society, Atlanta
National Cancer Institute. SEER Limited-Use Data. Available from URL: http://www.seer.cancer.gov/data/
Du XL, Meyer TE, Franzini L (2007) Meta-analysis of racial disparities in survival in association with socioeconomic status among men and women with colon cancer. Cancer 109:2161–2170
Polite BN, Dignam JJ, Olopade OI (2006) Colorectal cancer model of health disparities: understanding mortality differences in minority populations. J Clin Oncol 24:2179–2187
Alexander DD, Waterbor J, Hughes T, Funkhouser E, Grizzle W, Manne U (2007) African-American and Caucasian disparities in colorectal cancer mortality and survival by data source: an epidemiologic review. Cancer Biomark 3:301–313
Doubeni CA, Field TS, Buist DS, Korner EJ, Bigelow C, Lamerato L et al (2007) Racial differences in tumor stage and survival for colorectal cancer in an insured population. Cancer 109:612–620
Govindarajan R, Shah RV, Erkman LG, Hutchins LF (2003) Racial differences in the outcome of patients with colorectal carcinoma. Cancer 97:493–49
Brawley OW, Freeman HP (1999) Race and outcomes: is this the end of the beginning for minority health research? J Natl Cancer Inst 91:1908–1919
Marcella S, Miller JE (2001) Racial differences in colorectal cancer mortality. The importance of stage and socioeconomic status. J Clin Epidemiol 54:359–366
Mayberry RM, Coates RJ, Hill HA, Click LA, Chen VW, Austin DF et al (1995) Determinants of black/white differences in colon cancer survival. J Natl Cancer Inst 87:1686–1693
Wudel LJ Jr, Chapman WC, Shyr Y, Davidson M, Jeyakumar A, Rogers SO et al (2002) Disparate outcomes in patients with colorectal cancer: effect of race on long term survival. Arch Surg 137:550–554
Roxburgh CS, Salmond JM, Horgan PG, Oien KA, McMillan DC (2009) The Relationship Between the Local and Systemic Inflammatory Responses and Survival in Patients Undergoing Curative Surgery for Colon and Rectal Cancers. J Gastrointest Surg 13(11):2011–2018
Hill PG (1985) The measurement of albumin in serum and plasma. Ann Clin Biochem 22:565–578
Peters T (1985) Serum albumin. Adv Protein Chem 37:161–124
Fleck A, Raines G, Hawker F, Trotter J, Wallace PI, Ledingham IM et al (1985) Increased vascular permeability: a major cause of hypoalbuminaemia in disease and injury. Lancet 1:781–784
Harvy KB, Both A Jr, Blackburn GL (1979) Nutritional assessment and patient outcome during oncological therapy. Cancer 43:2065–2069
Dewys WD (1986) Nutritional factors and prognosis. In: Stoll BA (ed) Breast Cancer Treatment and Prognosis. Blackwell, Oxford, pp 188–199
Hause CA, Stocker MF, Tattersall MH (2006) Prognostic factors in patients with recently diagnosed incurable cancer: a systematic review. Support Care Cancer 14:999–1011
Read JA, Choy ST, Beale PJ, Clarke SJ (2006) Evaluation of nutritional and inflammatory status of advanced colorectal cancer patients and its correlation with survival. Nutr Cancer 55:78–85
Ishizuka M, Nagata H, Takagi K, Horie T, Kubota K (2007) Inflammation-based prognostic score is a novel predictor of outcome in patients with colorectal cancer. Ann Surg 246:1047–1051
Heys SD, Walker LG, Deehan DJ, Eremin OE (1998) Serum albumin: a prognostic indicator in patients with colorectal cancer. J R Coll Surg Edinb 43:163–168
Fuhrman MP, Charney P, Mueller CM (2004) Hepatic proteins and nutrition assessment. J Am Diet Assoc 104:1258–1264
Don BR, Kaysen G (2004) Serum albumin: Relationship to inflammation and nutrition. Semin Dial 17:432–437
Nakamura K, Moriyama Y, Kariyazono H, Hamada N, Toyohira H, Taira A et al (1999) Influence of preoperative nutritional state on inflammatory response after surgery. Nutrition 15:834–841
Fernandez-Reyes MJ, Alvarez-Ude F, Sanchez R, Mon C, Iglesias P, Diez JJ et al (2002) Inflammation and malnutrition as predictors of mortality in patients on hemodialysis. J Nephrol 15:136–143
Read JA, Beale PJ, Volker DH, Smith N, Childs A (2007) Clarke SJi. Nutrition intervention using an eiscosapentaenoic acid (EPA)-containing supplement in patients with advanced colorectal cancer. Effects on nutritional and inflammatory status: a phase II trial. Support Care Cancer 15:301–307
Ravasci P, Monteiro-Grillo I, Vidal PM, Camilo ME (2005) Dietary counseling improves patient outcomes: a prospective, randomized, controlled trial in colorectal cancer patients undergoing radiotherapy. J Clin Oncol 23:1431–1438
Conflicts of interest
No conflict of interest exists for all authors.
Author information
Authors and Affiliations
Corresponding author
Additional information
This manuscript has not been published previously, presently accepted, or under consideration for publication elsewhere.
Drs. McCutchen, Munoz, Brenner, Wludyka, and Vega each provided substantial contributions to study conception and design, acquisition of data, interpretation of data, manuscript drafting, and revising for intellectual content as well as approved this final version for submission.
Rights and permissions
About this article
Cite this article
McCutchen, A.S., Munoz, J.C., Brenner, L. et al. Lower albumin levels in African Americans at colon cancer diagnosis: a potential explanation for outcome disparities between groups?. Int J Colorectal Dis 26, 469–472 (2011). https://doi.org/10.1007/s00384-011-1134-7
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00384-011-1134-7